The cannabis-derived oral spray can now be prescribed for seizures associated with tuberous sclerosis complex (TCS), a rare genetic condition that causes benign tumors to develop in different parts of the body.
The Nevada Cannabis Compliance Board has begun investigating three state dispensaries for selling a product that twice failed microbial testing.
The scientists behind the new initiative at the National Institute of Standards and Technology also plan to help standardize the testing methods used for cannabis products, such as edibles, tinctures, and balms.
If given approval, the new regulations could come into effect in a matter of weeks.
A US company is voluntarily recalling a swathe of hemp tincture products, intended for dog, cat, and human consumption, after the Florida Department of Health tested some samples and found dangerous levels of lead.
Up until Green Peaks’ approval, any medical cannabis sold in Rhode Island dispensaries had either been tested by growers, by the dispensaries, or by unlicensed, private labs.
The review has paused over 50 applications from CBD companies hoping to acquire a “novel food” status for their products.